Search Weight Loss Topics:

Page 203«..1020..202203204205..210220..»

Home » Long Term Weight Loss » Page 203

Allergan Inc. is facing a federal subpoena concerning its controversial weight-loss surgical device, Lap-Band.

Lap-Band is implanted around the stomach to curb an obese persons appetite. It is designed to promote rapid weight loss but has been associated with a growing number of unexpected complications and side effects blamed not only on the device but also on the surgeons implanting it.

According to a Bloomberg report, the subpoena against Allergan has been sourced to the Dept. of Health and Human Services and concerns a recent Congressional call for a hearing to discuss the safety of Lap-Band after a report in Archives of Surgery associated the devices with an extremely high failure rate and a link to long term complications. That study found that about half of all Lap-Band recipients were contemplating a removal of the devices after just six years and nearly 40 percent of patients were bound to suffer long term pain and injuries rooted to the devices.

Earlier this year, despite growing evidence that Lap-Band could be defective and dangerous by design and that a vast number of surgeons havent been well-versed in proper procedures for implanting them, the Food and Drug Administration approved the surgery for people with less severe cases of obesity, potentially putting thousands more people at risk of similar injuries.

In Southern California, the Lap-Band and so-called boutique surgical centers created almost exclusively to implant these devices has been tied a growing controversy. The 1-800-GET-THIN billboard promotion in that area of the state has been stopped after it was learned the surgeons at associated surgery centers were not implanting them properly and had caused at least five deaths since 2009. The surgery centers implanting the devices in California were accused of not providing adequate warning of the risks associated with Lap-Band.

In addition to that risk, the design of Lap-Band has also been linked to serious complications, including erosion of the band through the stomach wall, stretching the esophagus, stretching the stomach pouch, stomach pain, gastroesophageal reflux disease, difficulty swallowing, nausea and vomiting.

These complications likely will lead to a life of pain and discomfort followed by possible repeated revision surgeries to adjust Lap-Band, or a surgery to remove the device far sooner than expected.

Lap-Band was first approved in 2001 for the treatment of morbid or serious obesity, for people at least 100 pounds overweight or for those with a Body Mass Index of 40 or greater. Prospective patients with lower BMI were also candidates for Lap-Band if they were suffering from a related condition such as heart disease which meant their obesity only increased their risks of suffering other related complications. An amended approval of Lap-Band earlier this year lower the minimum BMI for surgery candidates and put less restrictions on the severity and amount of related conditions a patient could have before receiving the device.

See more here:
Allergan Hit with Federal Subpoena Over Lap-Band Weight Loss Device

Portland, OR (PRWEB) May 08, 2012

Doctors of Weight Loss expert & co-founder, Dr. Emma Patterson, is sponsoring a contest in which one inspirational individual will receive a LAP-BAND procedure and one year of follow-up care, compliments of her practice, Oregon Weight Loss Surgery. The contest is sponsored by their Band Together for Weight Loss Campaign, which is an educational initiative that aims to educate consumers and healthcare professionals to work together to address the obesity epidemic. Dr. Emma Patterson, CEO and Medical Director of Oregon Weight Loss Surgery said, "this is an exciting contest, and the first of its kind in the Portland area. At Oregon Weight Loss Surgery my entire team is dedicated to helping people change their lives through weight loss surgery. We are excited to get the message out about the current obesity epidemic, and safe and successful treatments for this chronic disease, including bariatric surgery such as the Lap-Band." The goal of the campaign is to accomplish this through a dual focus on prevention and treatment, as well as acceptance of all effective treatments for obesity, including weight-loss surgery for people who are severely obese. Patterson said, "I love my work - its really fun seeing patients enjoy improved health and quality of life. Its particularly fun to be giving away a potentially life-saving surgery."

The contest winner will publicly share their long-term struggle with weight loss in an effort to encourage others struggling with being significantly overweight (generally 100 or more pounds overweight) to reclaim their health and their lives. To enter the Band Together for Weight Loss contest, individuals must submit a full length photo and a short essay (500-word max) explaining how their weight has had an impact on their health and life and why the LAP-BAND System may be the tool to help achieve their weight loss goal. The contest deadline is MAY 11th, 2012. More information about the contest can be found at http://www.oregonweightlosssurgery.com/

About Oregon Weight Loss Surgery and the Band Together for Weight Loss Campaign Oregon Weight Loss Surgery is the leading comprehensive weight loss surgery program serving patients in the Portland area. The program is overseen by Dr. Emma Patterson, who has more than 10 years of experience in weight loss surgery and has performed over 2,500 procedures. The Band Together for Weight Loss Campaign is an educational initiative with the goal of encouraging healthcare professionals and consumers to work together to address the obesity epidemic.

About Doctors of Weight Loss Co-founded by Emma Squillace and Dr. Emma Patterson, http://www.doctorsofweightloss.com is a resource for people who want to educate themselves about obesity and weight loss surgery. Doctors of Weight Loss brings together the top bariatric surgeons in the country to provide information for patients, family members, and healthcare professionals.

Read the original post:
Doctors of Weight Loss Co-Founder, Dr Emma Patterson, Giving Away Lap Band

May 10, 2012 1:43pm

Dr. Tom Lavin performs POSE surgery. (Shana Druckerman/ABC News)

Would you have surgery to lose 30 pounds? A controversial new procedure in weight loss has patients pleased but critics concerned.

In a quaint suburb of New Orleans, women are lining up for a new weight loss surgery called the POSE procedure. Short for Primary Obesity Surgery Endoluminol, the surgery is done outpatient andis incision-less. Dr. Tom Lavin, of Surgical Specialists, is one of only a few surgeons in the United States who is offering the procedure. He invited us down to see a surgery on one of his patients.

Theres a big difference between this new option and other, more common forms of bariatric surgery like gastric bypass, lap band, or sleeve gastrectomy. POSE is being marketed to women who want to lose 20 to 50 pounds as opposed to a typical weight loss surgery patient who drops 100 to 150 pounds. With the POSE procedure, everything is done through the mouth. An endoscope and surgical tools are used to pinch sections of the stomach, primarily the fundus area, and then sutured to make the stomach smaller. The size of cavity, according to Lavin, is typically reduced about 20 percent. His patients are reporting not only weight loss, but also fewer cravings.

Dr. Lavin wanted to make it clear that POSE has not worked for all of his patients. Heconceded that 15 to 20 percent are not affected by the procedure. And weight re-gain, just like with any other bariatric procedure, he says, is also a possibility.

When my producer and I raised this story in a staff meeting, several female colleagues were ready to sign up. POSE is promising news to a population of women (and men) who would normally never be considered for other bariatric procedures, but who still battle, through diet and exercise, to lose weight and keep it off.

But before you book your ticket to the bayou state you should know this: No long-term studies have been done in the U.S. to test the safety and effectiveness of the procedure. The device that is used for the surgery has been approved for other uses by the FDA, but does not yet have the sign off for weight loss surgery.

Other members of the bariatric community wont touch it without further study. Dr. Shawn Garber of New York Bariatrics warned, You are putting needles through the patients stomach, you are putting a device down through the esophagus, there are risks. And to put someone through the risk of those things without any proven benefit is definitely controversial.

In answer to colleagues, Lavin has this to say, When I came into surgery in the early 90s, everything was done open. Then people started doing things laparoscopically and it was a little questionable at first and they didnt know how is this going to go, and of course it changed everything.

Read more:
New Weight Loss Surgery: POSE Performed Through the Mouth

EXTON, Pennsylvania, May 3, 2012 /PRNewswire/ -- ViroPharma Incorporated announced three posters will be presented relating to long term data on Plenadren (hydrocortisone, modified release tablet) on May 7 at the 2012 joint 15th International Congress of Endocrinology and 14th European Congress of Endocrinology (ICE/ECE), held May 5 through 9, in Florence, Italy.

Embargo Lifts on Monday, May 7, at 00:01 hours local Florence time.

Poster Presentations

Poster ID: #78 Presenter: Anna Nilsson Title: An Open, Multi-Centre, Phase IIIb, Long-Term Follow-up Study to Assess the Safety, Tolerability and Efficacy of Once-Daily Oral Dual-Release Hydrocortisone in Patients with Adrenal Insufficiency Time: 18:00 - 19:30 hours local Florence time Location: Padiglione Spadolini - Attico at Fortezza da Basso Link: http://www.endocrine-abstracts.org/ea/0029/ea0029p78.htm [http://www.endocrine-abstracts.org/ea/0029/ea0029p78.htm]

Poster ID: #P50 Presenter: Gudmundur Johannsson Title: Intercurrent Illness Dose Regimen in Adrenal Insufficiency with a Dual-Release Hydrocortisone Formulation Derived from Population Pharmacokinetic Modeling Time: 18:00 - 19:30 hours local Florence time Location: Padiglione Spadolini - Attico at Fortezza da Basso Link: http://www.endocrine-abstracts.org/ea/0029/ea0029p50.htm [http://www.endocrine-abstracts.org/ea/0029/ea0029p50.htm]

Poster ID: #P76 Presenter: Maria Forss Title: Dosing Regimens for Glucocorticoid Replacement Therapy - A Worldwide Patient Survey of Patients with Adrenal Insufficiency Time: 18:00 - 19:30 hours local Florence time Location: Padiglione Spadolini - Attico at Fortezza da Basso Link: http://www.endocrine-abstracts.org/ea/0029/ea0029p76.htm [http://www.endocrine-abstracts.org/ea/0029/ea0029p76.htm]

About Plenadren (hydrocortisone, modified release tablet)

Plenadren is indicated for the treatment of adrenal insufficiency in adults.

Hypersensitivity to the active substance of Plenadren or to any of the excipients may occur. During acute adrenal insufficiency, parenteral administration of hydrocortisone in high doses, together with physiological sodium chloride solution for injection, must be given. Use of Plenadren with potent CYP 3A4 inducers and inhibitors may merit an adjustment of hydrocortisone dosage. High (supra-physiological) dosages of cortisone can cause elevation of blood pressure, salt and water retention, and increased excretion of potassium. Long-term treatment with higher than physiological hydrocortisone doses can lead to clinical features resembling Cushings syndrome with increased adiposity, abdominal obesity, hypertension and diabetes, and thus result in an increased risk of cardiovascular morbidity and mortality. All glucocorticoids increase calcium excretion and reduce the bone remodeling rate. Patients with adrenal insufficiency on long term glucocorticoid replacement therapy have been found to have reduced bone mineral density. Psychiatric adverse events may occur with systemic glucocorticoids.

The most common adverse reactions observed in clinical studies have been fatigue, gastroenteritis, upper respiratory tract infection, sedation, vertigo and dry eyes.

Read more from the original source:
ViroPharma Announces Upcoming Data Presentation Of Plenadren® (Hydrocortisone, Modified Release Tablet) At 2012 Joint ...

COLUMBUS, Ohio, May 3, 2012 /PRNewswire/ --Oxford Resource Partners, LP (OXF) (the "Partnership" or "Oxford") today announced first quarter 2012 financial results.

Overview

Following a challenging quarter, Oxford's management is highly focused on improving its profitability and liquidity through the actions below:

"We are taking rapid and decisive actions to improve operations," said Oxford's President and Chief Executive Officer Charles C. Ungurean. "We are focused on rightsizing our operations to match the currently challenging market conditions and to improve our profitability and liquidity. We are undertaking specific steps that include the ongoing restructuring of our Illinois Basin operations, which we expect will reduce Oxford's overall cost profile and enhance the productivity of our Northern Appalachian operations. By redeploying idled Illinois Basin equipment to our Northern Appalachian operations and selling excess Illinois Basin equipment, among other actions, we will reduce our planned 2012 capital outlays by $10 million and strengthen our balance sheet."

First Quarter 2012 Results

Net loss for the first quarter of 2012 was $15.8 million, or $0.75 per diluted limited partner unit, compared to a net loss for the first quarter of 2011 of $1.8 million, or $0.08 per diluted limited partner unit. First quarter 2012 results were impacted by impairment and restructuring charges related to the Illinois Basin operations and nonrecurring costs of $8.8 million, or $0.43 per diluted limited partner unit. Excluding these items, net loss for the first quarter of 2012 would have been $7.0 million, or $0.32 per diluted limited partner unit. Adjusted EBITDA(1) was $11.0 million for the first quarter of 2012 as compared to $14.0 million for the first quarter of 2011, impacted by a $4.88 per ton increase in cost of coal sales per ton primarily attributable to $3.8 million in higher diesel fuel costs. Distributable cash flow(1) was $0.1 million for the first quarter of 2012, down $5.4 million from the first quarter of 2011, reflecting the impact of a terminated sales contract, $3.8 million in higher diesel fuel costs and $0.8 million in higher cash interest expense.

(1) Definitions of adjusted EBITDA and distributable cash flow, which are non-GAAP financial measures, and reconciliations to comparable GAAP financial measures, are included in the non-GAAP financial measures table presented at the end of this press release.

Production and Sales Information Summary

Three Months Ended

March 31,

Read more:
Oxford Resource Partners, LP Reports First Quarter 2012 Financial Results

HARTFORD, Conn., May 1, 2012 /PRNewswire/ --Virtus Investment Partners, Inc. (VRTS), which operates a multi-manager asset management business, today reported a record level of total and long-term open-end mutual fund sales and net flows for the first quarter of 2012, and a 130 percent increase in operating income, as adjusted, from the first quarter of 2011.

(Logo: http://photos.prnewswire.com/prnh/20090105/NEM020LOGO )

Operating income, as adjusted, was $16.0 million for the quarter ended March 31, 2012, an increase from $7.0 million in the first quarter of 2011 and from $13.6 million in the fourth quarter of 2011. Operating margin, as adjusted, was 34 percent, compared with 21 percent in the prior year's first quarter and 32 percent in the fourth quarter of 2011. The February 24 launch of the Virtus Global Multi-Sector Income closed-end fund contributed $0.2 million to operating income, as adjusted, which excludes $4.5 million of up-front structuring fees, sales-related compensation, and fund offering costs.

Operating income for the first quarter, which includes $4.5 million of costs related to the closed-end fund launch, was $8.0 million with a margin of 13 percent, compared with $4.4 million and 10 percent in the first quarter of 2011 and $8.2 million with a margin of 15 percent in the fourth quarter of 2011. Net income for the quarter was $5.5 million or $0.68 per diluted share, an increase of 26 percent from $4.3 million or $0.43 per diluted share in the first quarter of 2011. Excluding the costs related to the fund launch, operating income and net income for the first quarter of 2012 would have been $12.4 million and $8.1 million, respectively. The company reported income tax expense of $3.6 million, at an effective tax rate of 40 percent, of which $3.5 million, or a rate of 38.6 percent, reflects the utilization of deferred tax assets and $0.1 million, or a rate of 1.4 percent, reflects the current tax obligation.

Operating income, as adjusted, and operating margin, as adjusted, are non-GAAP measures that exclude certain non-cash and other items, including the closed-end fund launch costs and transition costs for the Newfleet Multi-Sector team. These measures are further described and reconciled to GAAP measures at the end of the release.

Assets under management were $38.0 billion at March 31, 2012, an increase of 19 percent from March 31, 2011 and 10 percent from December 31, 2011. Long-term assets under management, which exclude cash management products, were $36.2 billion at the end of the first quarter, an increase of 27 percent from March 31, 2011 and 13 percent from December 31, 2011.

Financial Highlights (Unaudited)

(Dollars in thousands, except per share data or as noted)

In evaluating its performance, the company considers certain non-GAAP measures, including operating income, as adjusted, operating margin, as adjusted, operating expenses, as adjusted, and revenue, as adjusted, that are described and reconciled to GAAP-reported amounts in the table at the end of the release. These non-GAAP measures net the distribution and administration expenses against the related revenue and also exclude certain other cash and non-cash items.

Three Months Ended

See original here:
Virtus Investment Partners Announces Financial Results For the First Quarter of 2012

The three things we can control weight, exercise and diet are the principal factors in developing or escalating type 2 diabetes.

No surprise there.

Nor in the conclusion that many people have a genetic pre-disposition to type 2 diabetes.

And whos surprised to learn losing weight is the solution?

Ah, but wait on weight (couldnt resist that!) It may be easier than you think, says Dr. Donald Hensrud, chair of the Division of Preventive, Occupational and Aerospace Medicine and a consultant in the Division of Endocrinology and Nutrition at Mayo Clinic in Rochester, Minn.

His titles are a mouthful, but Hensrud, listed as main author of The Mayo Clinic Diabetes Diet, takes a refreshingly simple look at dieting.

Question: This is one of the easiest diet books to understand and follow. It stresses vegetables, fruits, whole grains, lean sources of protein and healthy fats but its actually fun to read about this.

Answer: The book starts with a two-week program to lose weight in a safe and healthy way and then goes on into a plan to lose 1 to 2 pounds a week until you reach your goal. And then there are the meal planners and recipes and so on.

Q: Very similar to the regular Mayo Clinic diet book. But what I want to mention is the way that you stress exercise. Couple the age of some people with this problem I mean, a person could be well into their 70s when they find out they have type 2 diabetes isnt developing an exercise program a real challenge?

A: Of course. There isnt a perfect answer for everyone either. But everyone must do some type of physical activity. I remember my grandmother, when she was well into her 80s, doing laps around the dining room table. Some of the practical implementation is right up front. Once you see some success, then the rest of the program can be adopted and turned into a long-term lifestyle program.

Continue reading here:
Mayo Clinic doctor provides simple, bite-sized steps to weight loss

LOS ANGELES, May 1, 2012 /PRNewswire/ -- When patients and doctors come together and fully commit to weight loss, the results can be staggering. The advent of specialized procedures like the STARR Treatment have revolutionized bariatric surgery, making operations like gastric bypass, sleeve gastrectomy, and the Lap Band safer, more effective, and less invasive than ever before. At the same time, patients are more knowledgeable now about their options, allowing them to make a more informed decision about the best course of action. Responsible surgeons like Dr. Michael Feiz make sure patients know that weight loss surgery is not a silver bullet, and that real and lasting success requires not only a high-caliber surgeon's deft skills, but also total commitment from the patient. By encouraging an open dialogue with his patients, and asking as much from them as he asks of himself and his team of medical professionals, Dr. Feiz has produced one success story after another.

At Dr. Feiz & Associates, a reputable weight loss center in Beverly Hills, Dr. Feiz and his fellow surgeons are blazing new trails. The STARR Treatment, which only a few surgeons in the United States are qualified to use, enables this team to perform dramatic weight loss surgery with only a single incision. If you have been hesitant to go under the knife because of concern about scars, or painful post-operative recovery, the STARR Treatment may represent an appealing alternative.

Nevertheless, bariatric surgery should not be entered into lightly. Dr. Feiz spends a lot of time consulting with prospective patients to determine what, if any, procedure may be right for them. A lot goes into this final determination, from your BMI (Body Mass Index) to co-morbidities (obesity-related health issues such as hypertension and diabetes), and many other considerations. You may be an ideal candidate for gastric bypass or sleeve gastrectomy. Other patients who may need a less-invasive option have come to Dr. Feiz for the increasingly popular Lap Band in Beverly Hills.

In consulting with Dr. Feiz, patients also need to show a readiness to dedicate themselves to the long-term lifestyle changes required to keep the weight off after surgery. Bariatric surgery isn't a path to which you resign yourself; it is a path to which you dedicate yourself. By sticking with patients long after surgery, helping them adhere to the larger plan for weight loss, Dr. Feiz ensures that weight loss becomes an ongoing team effort.

To learn more about these procedures, and about Dr. Feiz himself, visit online at http://www.drfeiz.com.

PR submitted by http://www.Cyberset.com

Original post:
Surgical Weight Loss is a Team Effort Between Doctors and Patients

TULSA, Okla., May 2, 2012 (GLOBE NEWSWIRE) -- The hCG weight loss diet is designed to help patients who suffer from conditioned hyper eating, a condition where patients struggle to lose weight even when the exercise and eat healthy. According to Dr. Drew Lawrence, chiropractor with HealthSource of Tulsa, small doses of the hCG hormone can help the body burn fat and promote weight loss -- naturally increasing energy without causing nervousness or anxiety side effects.

Dr. Drew Lawrence and Dr. Scottie Lawrence announced that their wellness center offers the hCG weight loss diet, along with comprehensive nutritional counseling and weight management services. According to the chiropractic physicians, the hCG program has been extremely effective in helping patients lose weight.

"Many of our patients have tried other diets without any long-term success," said Dr. Drew Lawrence. "The hCG program is different; it's an effective way to jump start weight loss and has helped more than 15,000 people across the United States, including many right here in Tulsa."

The hCG hormone naturally occurs during pregnancy. For many years, the hormone was used to improve fertility in women who struggled to conceive. Recently, new scientific studies suggest that the hormone, in conjunction with a low calorie diet, may help promote long-term weight loss.

Patients who participate in the program will receive a low daily hormone dose. According to Dr. Scottie Lawrence, this low dose triggers the brain to burn stored fat, which helps patients safely lose weight.

According to Dr. Drew Lawrence, the hCG diet is designed to help patients who suffer from "Conditioned Hyper Eating." Dr. Drew Lawrence says this condition is a primary reason why so many people repeatedly try -- and fail -- to lose weight.

"Have you ever opened the fridge just to search for food, or polished off an entire bag of chips without even realizing it?" asked Dr. Drew Lawrence. "These are all signs of conditioned hyper eating. Patients who suffer from this condition will continue to gain weight even when the exercise and eat healthy. The hCG hormone helps to stop this behavior by naturally increasing energy levels. This helps the body burn energy and decrease the desire to aimlessly eat."

Dr. Drew Lawrence says that the hCG diet is successful because of its holistic approach to weight loss. The hormone injections may help reset a patient's metabolism, while behavioral counseling helps patients rethink their relationship with food.

"We strongly encourage anyone who is struggling to take off the pounds to learn more about the hCG diet," said Dr. Scottie Lawrence. "I've seen first-hand the difference it can make in people's lives. Our message is simple: if you are overweight and feeling frustrated, don't give up hope."

Prospective patients who visit the practice's website, http://healthsourcetulsa.com, may also read testimonials from hCG diet patients. In addition to the hCG diet, the chiropractic care center provides comprehensive wellness services. These include chiropractic adjustments for pain management, physical therapy, and car accident injury treatment.

Continue reading here:
HealthSource of Tulsa: hCG Weight Loss Program Helps Patients Successfully Lose Weight

POTOMAC, Md., April 24, 2012 /PRNewswire/ --Healthy Directions, a leading health publisher and provider of proprietary, doctor-formulated nutritional supplements, announced today the launch of beauty and health expert Dr. Aaron Tabor's new line of synergistic skincare products and dietary supplements designed for discerning women looking for an effective way to naturally reduce the signs of aging from the inside out.

Available exclusively through HealthyDirections.com, the new collection of anti-aging skincare solutions is formulated from clinically proven ingredients that nourish, protect and repair the skin both inside and outside, from head to toe. Dr. Tabor's "Inside Out Beauty" philosophy is designed to help women take care of their skin "full force, full time" and includes a proprietary combination of scientifically proven ingredients he calls the Neurocellular Core-T Complex. Dr. Tabor's skincare formulations also follow strict European safe beauty standards and are pure and free of any known harmful ingredients.

"Contrary to what we may be told by plastic surgeons and dermatologists, new nutritional science confirms we can reverse the signs of aging by using full force ingredients throughout our lifespan," says Dr. Tabor. "By combining topical treatments at the appropriate concentrations with supplemental nutritional ingredients internally, the result is a medical synergy that fights and reverses the visible signs of aging in each layer of the skin. Working with Healthy Directions has enabled me to bring this synergistic line of anti-aging products to life, providing people with the tools they need to combat the effects of aging in their twenties, thirties, forties, fifties, and beyond."

Dr. Tabor's new line of skincare products include:

Additional Healthy Directions products from Dr. Tabor include a cleanser with exfoliant, eye cream and a collection of Slim & Beautiful Diet products.

Dr. Tabor joins the team of expert doctors at Healthy Directions, leaders in the fields of alternative and integrative healthcare practices who have earned reputations as the world's leading authorities in natural healing. Their goal is to help people live longer, healthier, and more vibrant lives through natural remedies, lifestyle changes, and cutting-edge nutritional therapies.

"We know consumers are constantly looking for safe, all-natural options to fight the signs of aging. Dr. Tabor, one of the top physician researchers in the country, has met that need with his new collection of products that target each of the seven layers of the skin from the inside out - a new concept that is changing the way we think about skincare," said Healthy Directions Executive Vice President Connie Hallquist.

In addition to offering Dr. Tabor's new line of products, the Healthy Directions website will feature information on Dr. Tabor's skincare philosophy, and include tips for optimal total body beauty. One can also review nutrients known for repairing the skin, healthy food recommendations, general tips for optimal wellness and skincare regimens.

To learn more about Dr. Tabor's skincare products, visit http://www.HealthyDirections.com.

About Healthy Directions

See the rest here:
Dr. Aaron Tabor Launches New "Inside Out Beauty" Concept in Skincare and Weight Loss

Page 203«..1020..202203204205..210220..»

Home » Long Term Weight Loss » Page 203